Invesaro

Stocks UVV Financial statements

Financial statements

UNIVERSAL CORP /VA/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UNIVERSAL CORP /VA/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue2,0712,0342,2131,8921,9652,0912,5502,7222,9232,885
Cost of revenue1,6771,6621,8211,5531,5971,6952,1122,2122,3992,412
Gross profit395372393339368396438509524473
Selling, general and administrative212201225223220241277311305301
Operating income178171161126148160181222233168
Interest expense16.315.617.519.92527.749.366.379.674
Interest income1.41.691.531.580.330.926.024.53.481.96
Other non-operating income-0.050.660.830.99-0.442.691.793.082.572.85
Pre-tax income169167151113126142142164154103
Income tax56.750.541.235.329.438.711.731.140.946.7
Net income to minority interests6.210.56.016.328.9176.1813.418.223.4
Net income10610610471.787.486.61241209532.6
EBITDA214206198165193213238280293222
EPS, basic0.894.184.142.873.553.505.014.813.811.30
EPS, diluted0.884.144.112.863.533.474.974.783.781.30
Shares, basic (weighted)23.425.325.12524.724.824.824.924.925
Shares, diluted (weighted)23.825.525.325.124.824.924.92525.125.2
Dividend per share2.142.183.003.043.083.123.163.203.243.28

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents28423429810719781.664.755.626062.2
Receivables439377368341367385402525626564
Other current assets81.388.271.267.566.811799.893.77897.3
Total current assets1,5611,5891,5881,4801,5551,7481,8032,1032,1561,972
Property, plant and equipment317324302315350345351366373373
Lease right-of-use assets039.331.240.240.532.534.337.3
Goodwill98.898.897.9127173214214214214173
Intangible assets0.0917.972.392.680.168.957.848.6
Other non-current assets41.950.450.743.752.241.151.350.245.949.1
Total assets2,1232,1692,1332,1212,3422,5862,6392,9372,9902,767
Accounts payable154164146140139272
Accrued liabilities3227.931.423.729.927.333.139.844.633.2
Deferred revenue21.710.28.7713.73.0617.23.763.38
Short-term debt0000000000
Total current liabilities268268254267293519442711750564
Long-term debt369369369369518519617617618617
Lease liabilities025.919.729.625.519.320.624.4
Other non-current liabilities31.44643.269.459.834.532.527.922.924.9
Total liabilities7977837538329931,2021,2021,4581,4891,306
Total debt370370370369518519617617618617
Retained earnings1,0351,0811,1061,0771,0881,0941,1371,1731,1871,137
Other comprehensive income-69.6-60.1-95.7-152-107-84.3-77.1-81.6-80.1-73.1
Shareholders' equity1,2861,3421,3371,2471,3071,3411,3971,4371,4591,415
Minority interests40.142.942.842.641.144.239.941.74245.7
Total equity1,3271,3851,3801,2891,3481,3851,4371,4791,5011,461
Total liabilities and equity2,1232,1692,1332,1212,3422,5862,6392,9372,9902,767
Shares outstanding25.324.92524.424.524.624.624.624.724.9

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income1131161107896.310413013311356
Depreciation and amortization3634.937.138.444.752.557.358.359.853.4
Stock-based compensation6.487.618.155.636.116.198.4212.18.537.12
Deferred income tax16.6-11.13.87-8.7-2.34-2.47-7.66-5.411.08-0.96
Change in inventory54.6-246-41.9-236245-89.5
Change in payables30.713.4-54.9-48.511.3109-84.620.8-8.7-12.6
Cash from operations25081.216510.922044.9-10.6-74.6327129
Capital expenditures-35.6-34-38.8-35.2-66.2-53.2-54.7-66-62.6-48.8
Acquisitions000-80.2-162-10200
Cash from investing-33.9-27.4-34.7-106-217-143-50.4-60-58.8-43
Debt issued0041.1015001230089.1
Debt repaid00-41.1000-23.500-89.1
Stock issued0
Share buybacks0-21.6-1.44-33.50-3.05-3.45-4.7400
Dividends paid-49.8-54.7-69.9-75.4-75.2-76.4-77.4-78.4-79.7-81.3
Cash from financing-251-105-65.8-94.191.4-16.838.9126-63.2-284
Exchange rate effect-0.670.93-0.61-0.511.26-1.03-1-0.14-0.40.26
Net change in cash-35.5-49.963.4-19095.8-116-23-9.1205-198
Free cash flow21547.2126-24.3154-8.32-65.2-14126480.3
Interest paid16.315.616.519.424.227.149.961.175.371.8
Income taxes paid37.358.344.93136.43349.138.138.443.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $42.47 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin15.6%Gross profit / revenue.
Operating margin4.9%Operating income / revenue.
EBITDA margin6.7%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin0.7%Net income / revenue.
FCF margin5.8%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin7.7%Cash from operations / revenue.
Return on equity (ROE)1.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)0.6%Net income / average total assets.
Return on invested capital (ROIC)5.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue10.7%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.9%Capital expenditures / revenue.
D&A / revenue1.9%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-1.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y8.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-9.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y2.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-27.6%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-2.4%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y2.6%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-24.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-2.4%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y2.9%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-65.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-35.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-17.9%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-65.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-36.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-18.1%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-60.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y-10.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-69.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y-12.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y1.2%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y1.3%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y1.3%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-3.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y0.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y1.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-7.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.57xCurrent assets / current liabilities.
Quick ratio0.60x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.20x(Cash + short-term investments) / current liabilities.
Debt / equity0.44xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets20.3%Total debt / total assets.
Liabilities / assets53.1%Total liabilities / total assets.
Net debt$443.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.34xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage1.88xOperating income / interest expense.
Working capital$1.37BCurrent assets - current liabilities.
Goodwill and intangibles / assets7.2%(Goodwill + intangible assets) / total assets.
Tangible book value$1.17BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.93xRevenue / average total assets.
Fixed asset turnover7.47xRevenue / average property, plant and equipment.
Receivables turnover8.08xRevenue / average receivables.
Days sales outstanding45 days365 x average receivables / revenue.
FCF conversion859.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow24.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.76Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$112.14Revenue / diluted weighted shares.
FCF per share$6.55Free cash flow / diluted weighted shares.
Operating cash flow per share$8.66Cash from operations / diluted weighted shares.
Book value per share$55.37Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$46.63Tangible book value / shares outstanding.
Cash per share$6.92(Cash + short-term investments) / shares outstanding.
Payout ratio427.3%Dividends paid / net income, when net income is positive.
Dividends / FCF49.7%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.06BShare price x shares outstanding.
Enterprise value$1.50BMarket cap + total debt - cash - short-term investments.
P/E55.3xMarket cap / net income. Only when net income is positive.
P/S0.38xMarket cap / revenue.
P/B0.76xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.90xMarket cap / tangible book value, when positive.
P/FCF6.43xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF4.87xMarket cap / cash from operations, when positive.
EV/Sales0.53xEnterprise value / revenue.
EV/EBIT11.0xEnterprise value / operating income, when both are positive.
EV/EBITDA7.92xEnterprise value / EBITDA, when both are positive.
EV/FCF9.13xEnterprise value / free cash flow, when both are positive.
FCF yield15.5%Free cash flow / market cap.
Earnings yield1.8%Net income / market cap (the inverse of P/E).
Dividend yield7.7%Dividends paid over the period / market cap.
Shareholder yield7.7%(Dividends paid + share buybacks) / market cap.
What was UNIVERSAL CORP /VA/'s revenue in fiscal 2026?

UNIVERSAL CORP /VA/ reported revenue of $2.89B for fiscal 2026, 1.3% lower than the year before.

Was UNIVERSAL CORP /VA/ profitable in fiscal 2026?

Yes. Net income was $32.6M, a net margin of 1.1%.

How much free cash flow did UNIVERSAL CORP /VA/ generate in fiscal 2026?

Cash from operations of $129.1M minus capital expenditures of $48.8M left free cash flow of $80.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to UNIVERSAL CORP /VA/